Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Synairgen’s inhaled COVID-19 treatment included in US trial

pharmatimesFebruary 25, 2021

Tag: COVID-19 , ACTIV-2 , Synairgen

PharmaSources Customer Service